Articles |
From the Departments of Internal Medicine (H.T., F.M.F., T.K., D.D.H.) and Pharmacology (F.M.F., D.D.H.), Center on Aging and Cardiovascular Center, University of Iowa College of Medicine, and the Veterans Administration Medical Center, Iowa City.
Correspondence to Donald D. Heistad, MD, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242.
| Abstract |
|---|
|
|
|---|
Key Words: glibenclamide ATP-sensitive potassium channels iberiotoxin endothelium-derived relaxing factor NG-nitro-L-arginine
| Introduction |
|---|
|
|
|---|
Endothelium-dependent relaxation is impaired during hypercholesterolemia and atherosclerosis,9 10 11 12 and relaxation of arteries in response to activation of potassium channels may also be impaired by atherosclerosis.13 If hypoxia-induced vasorelaxation is mediated by either release of EDRF or activation of potassium channels, we anticipated that vasorelaxation in response to hypoxia would be impaired during atherosclerosis. Thus, the goal of the present study was to examine mechanisms of vascular relaxation to hypoxia in normal and WHHL rabbits and to determine whether relaxation of the carotid artery in response to hypoxia is impaired in WHHL rabbits.
| Methods |
|---|
|
|
|---|
Rabbits were anesthetized with sodium pentobarbital (40 to 60 mg/kg IV), and the carotid artery was immediately removed and placed in Krebs' buffer with the following composition (in mmol/L): NaCl 118.3, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25, and glucose 12. Connective tissue and fat on the adventitia vascular surface were carefully removed, and the vessel was cut into rings 3 to 4 mm in length. The rings were suspended in an organ bath with 20 mL Krebs' buffer maintained at 37°C and bubbled with a mixture of 95% O2 and 5% CO2.14 The rings were connected to a force transducer to measure isometric tension. Resting tension was increased in a stepwise manner to reach the final tension of 2 g over 30 minutes, and the rings were allowed to equilibrate for 30 minutes, during which the buffer was replaced at 15-minute intervals. Vessels were contracted twice with 85 mmol/L KCl, with 45 minutes between contractions. In preliminary experiments, concentration-response curves to phenylephrine (10-8 to 10-4 mol/L) were obtained, and the concentration of phenylephrine that produced 50% to 60% of the maximum contractile response (EC50-60) was used in subsequent studies. Results are expressed as percent relaxation of contraction produced by phenylephrine.
Experimental Protocol
After contraction with phenylephrine reached a
plateau, the gas aerating the organ bath was switched from the control
mixture (95% O2 and 5% CO2) to a mild hypoxic
mixture (5% O2, 5% CO2, and
90% N2), and changes in vascular tension were measured.
After relaxation of the carotid artery in response to mild
hypoxia reached a plateau, the tank was switched to produce a
severe hypoxia (5% CO2 and 95% N2).
During mild and severe hypoxia, PO2
in the Krebs' buffer decreased from 449±17 mm Hg to 72±2 and 44±2
mm Hg, respectively. pH and PCO2 were not
altered.
In normal rabbits, we examined the effects of the nitric oxide synthase inhibitor L-NNA (10-4 mol/L)15 and denudation of the endothelium on vasorelaxation during mild and severe hypoxia. L-NNA was dissolved in Krebs' solution and was applied 30 minutes before and during exposure to hypoxic conditions. The concentration of L-NNA abolished acetylcholine-induced relaxation of the carotid artery without inhibiting vasorelaxation in response to sodium nitroprusside (data not shown). To produce endothelial cell denudation, the intima was gently rubbed with forceps inserted into the lumen. Vessels did not relax in response to acetylcholine after endothelial denudation but relaxed normally in response to sodium nitroprusside (data not shown).
We also examined the effects of two potassium-channel inhibitors on relaxation of the carotid artery during hypoxia in NZW and WHHL rabbits. Glibenclamide (10-6 mol/L), an inhibitor of ATP-sensitive potassium channels,16 17 or iberiotoxin (5x10-8 mol/L), an inhibitor of calcium-activated potassium channels,18 19 20 was applied 10 minutes before exposure to hypoxic conditions. Glibenclamide was dissolved in dimethyl sulfoxide (0.1%), and control experiments were performed in the presence of 0.1% dimethyl sulfoxide alone.
We also examined changes in tension of the carotid artery in response to aprikalim (10-7 to 10-6 mol/L), a direct activator of ATP-sensitive potassium channels,16 17 acetylcholine (10-8 to 10-7 mol/L), and sodium nitroprusside (10-8 to 10-6 mol/L) in control and WHHL rabbits.
Histological Procedures
After measurements were made in the organ bath, the vascular
rings were fixed, processed for paraffin embedding, and stained with
hematoxylin and eosin.
Statistical Analysis
All data are expressed as mean±SEM. Student's t
test was used to compare absolute values, and the Mann-Whitney
U test was used to compare percent changes. A probability of
<.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
In other experiments we tested the effects of iberiotoxin (5x10-8 mol/L), an inhibitor of calcium-activated potassium channels,18 19 20 on hypoxia-induced vasorelaxation. In contrast to glibenclamide, iberiotoxin did not significantly impair relaxation in response to either mild or severe hypoxia. In response to mild and severe hypoxia, respectively, the carotid artery relaxed by 22±3% and 94±5% in the absence and 14±6% and 83±8% in the presence of iberiotoxin (P>.05 for both).
Hypoxia in WHHL Rabbits
Relaxation of the carotid artery in response to mild and severe
hypoxia was less in WHHL than in normal rabbits
(P<.05; Fig 3
). Glibenclamide
(10-6 mol/L) tended to reduce relaxation in response to
mild hypoxia and inhibited responses to severe hypoxia
by 71±10% in WHHL rabbits (Fig 4
). In contrast,
glibenclamide did not attenuate relaxation of the carotid artery in
response to nitroprusside in WHHL rabbits (data not shown).
|
|
Responses of the Carotid Artery to Acetylcholine, Nitroprusside,
and Aprikalim
Relaxation of the carotid artery in response to acetylcholine was
less in WHHL than in normal rabbits (P<.05; Fig 5
). Responses to sodium nitroprusside were generally
similar in normal and WHHL rabbits (Fig 5
).
|
Aprikalim, an activator of ATP-sensitive potassium
channels,16 17 produced relaxation of the carotid artery
that was similar in normal and WHHL rabbits (Fig 6
).
Glibenclamide (10-6 mol/L) almost abolished relaxation of
the carotid artery in response to aprikalim (data not shown). These
findings suggest that ATP-sensitive potassium channels are present
and functional in the carotid artery of normal and WHHL rabbits.
|
Histological Study
The common carotid artery from NZW and WHHL rabbits had no visible
macroscopic or microscopic evidence of atherosclerotic lesions. In
contrast, the thoracic aorta from WHHL rabbits had lesions
characterized by pronounced intimal thickening and lipid
deposition.
| Discussion |
|---|
|
|
|---|
Responses to Acetylcholine and Sodium Nitroprusside
There is substantial evidence that
endothelium-dependent relaxation is impaired by
hypercholesterolemia or
atherosclerosis in humans and animals.9 10 11 12
The present findings support this concept. Relaxation of the
carotid artery in response to acetylcholine was less in WHHL than in
normal rabbits. Endothelium-dependent relaxation of
the carotid artery in response to acetylcholine was decreased in WHHL
rabbits even though the vessels appeared morphologically normal.
Relaxation of the carotid artery in response to nitroprusside was generally similar in WHHL and normal rabbits, with a very modest reduction in relaxation to the highest concentration of nitroprusside in WHHL rabbits. Preservation of responses to nitroprusside suggests that impaired relaxation in response to acetylcholine in WHHL rabbits is relatively specific and not due to generalized dysfunction of the vascular muscle.
Responses to Aprikalim
Activation of ATP-sensitive potassium channels is an
important mechanism of vasorelaxation.12 21 22 23
Aprikalim, a direct activator of ATP-sensitive
potassium channels,16 17 produced similar relaxation of
the carotid artery in normal and WHHL rabbits. Glibenclamide, an
inhibitor of ATP-sensitive potassium channels, produced
marked inhibition of relaxation in response to aprikalim. High
concentrations of glibenclamide may inhibit large-conductance
calcium-activated potassium channels24 as well
as ATP-sensitive potassium channels. The concentration of glibenclamide
used in this study, however, is considered to be relatively specific
for ATP-sensitive potassium channels.18 Thus, our findings
suggest that ATP-sensitive potassium channels are present in the
carotid artery in normal and WHHL rabbits and that relaxation in
response to activation of ATP-sensitive potassium channels is not
affected by hypercholesterolemia.
Relaxation of the carotid artery in response to aprikalim is less in atherosclerotic than in normal monkeys.13 In the present study, we used segments of the carotid artery that had no detectable atherosclerotic lesions. Thus, preservation of responses to aprikalim in the present studies may be related to the absence of atherosclerotic lesions. Taken together, the present findings and the study in monkeys13 suggest that atherosclerosis but not hypercholesterolemia without atherosclerotic lesions impairs responses to activation of glibenclamide-sensitive potassium channels.
Vasorelaxation in Response to Hypoxia
Removal of the endothelium inhibited relaxation of
the carotid artery from normal rabbits during mild hypoxia.
This relaxation was also partially inhibited by L-NNA, suggesting that
relaxation of the carotid artery from normal rabbits during mild
hypoxia is mediated, in part, by EDRF. Because vasorelaxation
during mild hypoxia was not completely inhibited by L-NNA, it
is possible that other mechanisms, such as release of an
endothelium-derived hyperpolarizing factor, are
also involved. Although endothelium-derived nitric
oxide may act as an endothelium-derived
hyperpolarizing factor in some vessels, earlier data in normal rabbit
carotid arteries suggest that this is not the case.25
Glibenclamide also produced some inhibition of the relaxation response, suggesting that activation of glibenclamide-sensitive potassium channels may be involved in relaxation of the carotid artery during mild hypoxia. It is not clear whether mild hypoxia increases production of EDRF or prolongs its activity. Vascular endothelium appears to contain ATP-sensitive potassium channels,26 and hyperpolarization produced by activation of potassium channels in endothelium may activate calcium influx through receptor-operated cation channels27 and thereby release EDRF. Alternatively, reduction in formation of oxygen radicals, which inactivate EDRF,28 during mild hypoxia may also contribute to enhanced activity of EDRF in isolated vessels.
Glibenclamide inhibited relaxation of the carotid artery during both mild and severe hypoxia. Because removal of endothelium did not affect vasorelaxation in response to severe hypoxia, glibenclamide-sensitive potassium channels (but not EDRF) appear to be activated in vascular muscle during severe hypoxia. Because glibenclamide did not completely inhibit vasorelaxation during hypoxia, other mechanisms may also contribute to relaxation in response to hypoxia.
To examine the specificity of glibenclamide and the possible contribution of other potassium channels, we also tested effects of iberiotoxin, an inhibitor of calcium-activated potassium channels,19 20 on hypoxia-induced vasorelaxation. Iberiotoxin did not affect relaxation of the carotid artery in response to mild or severe hypoxia, which suggests that activation of calcium-dependent potassium channels does not contribute to vasorelaxation during hypoxia.
Hypoxia-Induced Vasorelaxation in WHHL
Rabbits
Mild hypoxia produced less relaxation of the carotid
artery in WHHL than in normal rabbits. Our data suggest that
vasorelaxation in response to mild hypoxia is mediated
primarily by EDRF in normal rabbits, and
endothelium-dependent relaxation of the carotid
artery is impaired in WHHL rabbits. Thus, impaired responses of the
carotid artery to mild hypoxia may be due to impaired
endothelium-dependent relaxation in WHHL
rabbits.
Severe hypoxia produced less relaxation of the carotid artery in WHHL than in normal rabbits, and glibenclamide inhibited this response. Thus, although vasorelaxation during severe hypoxia is impaired in WHHL rabbits, activation of glibenclamide-sensitive potassium channels is the primary mechanism by which severe hypoxia produces vasorelaxation, and the glibenclamide-dependent response is preserved in WHHL rabbits. This finding is compatible with our finding that responses to activation of ATP-sensitive potassium channels by aprikalim are preserved in WHHL rabbits. Because relaxation of the carotid artery during severe hypoxia is endothelium independent, these findings suggest that impaired responses to severe hypoxia occur at the level of vascular muscle.
In conclusion, relaxation of the carotid artery in response to mild and severe hypoxia is mediated by glibenclamide-sensitive potassium channels in both normal and hyperlipidemic rabbits. The response to mild hypoxia is largely mediated by EDRF in normal rabbits. Vasorelaxation in response to mild hypoxia is impaired in WHHL rabbits, probably because endothelium-dependent relaxation is impaired.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received March 16, 1995; accepted July 11, 1995.
| References |
|---|
|
|
|---|
2.
Yang BC, Mehta JL. Prior episode of anoxia
attenuates vasorelaxation in response to subsequent episode of
anoxia. Am J Physiol. 1994;266:H974-H979.
3.
Taguchi H, Faraci FM, Kitazono T, Heistad DD.
Relaxation of the aorta during hypoxia is impaired in
chronically hypertensive rats.
Hypertension. 1995;25:735-738.
4. Wadsworth RM. Vasoconstrictor and vasodilator effects of hypoxia. Trends Pharmacol Sci. 1994;15:47-53. [Medline] [Order article via Infotrieve]
5.
Park KH, Rubin LE, Gross SS, Levi R. Nitric
oxide is a mediator of hypoxic coronary vasodilatation:
relation to adenosine and
cyclooxygenase-derived metabolites.
Circ Res. 1992;71:992-1001.
6.
Pohl U, Busse R. Hypoxia stimulates
release of endothelium-derived relaxant
factor. Am J Physiol. 1989;256:H1595-H1600.
7.
Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G,
Gunther K, Goedel-Meinen L. Hypoxic dilation of coronary
arteries is mediated by ATP-sensitive potassium channels.
Science. 1990;247:1341-1344.
8. Gebremedhin D, Bonnet P, Greene AS, England SK, Rusch NL, Lombard JH, Harder DR. Hypoxia increases the activity of Ca2+-sensitive K+ channels in cat cerebral arterial muscle cell membranes. Pflugers Arch. 1994;428:621-630. [Medline] [Order article via Infotrieve]
9. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 1990;336:897-900. [Medline] [Order article via Infotrieve]
10.
Forstermann U, Mugge A, Alheid U, Haverich A, Frolich
JC. Selective attenuation of
endothelium-mediated vasodilatation in
atherosclerotic human coronary arteries.
Circ Res. 1988;62:185-190.
11. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993;91:29-37.
12. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 1987;80:1808-1811.
13. Faraci FM, Orgren K, Heistad DD. Impaired relaxation of the carotid artery during activation of ATP-sensitive potassium channels in atherosclerotic monkeys. Stroke. 1994;25:178-182. [Abstract]
14. Kenakin TP. Isolated-tissue response systems. In: Pharmacologic Analysis of Drug-Receptor Interaction. New York, NY: Raven Press; 1987:52-84.
15. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142. [Medline] [Order article via Infotrieve]
16. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol. 1993;33:597-637. [Medline] [Order article via Infotrieve]
17. Aloup JC, Farge D, James C, Mondot S, Cavero I. 2-(3-pyridyl)-tetrahydrothiopyran-2-carbothiamide derivative and analogues: a novel family of potent potassium channel openers. Drug Future. 1990;15:1097-1108.
18. Escande D, Cavero I. K+ channel openers and `natural' cardioprotection. Trends Pharmacol Sci. 1992;13:269-271. [Medline] [Order article via Infotrieve]
19. Nelson MT. Ca2+-activated potassium channels and ATP-sensitive potassium channels as modulators of vascular tone. Trends Cardiovasc Med. 1993;3:54-60.
20.
Galvez A, Gimenez-Gallego G, Reuben JP,
Roy-Contancin L, Feigenbaum P, Kaczorowski GJ, Garcia ML.
Purification and characterization of a unique, potent, peptidyl
probe for high conductance calcium-activated potassium
channel from venom of the scorpion Buthus tamulus.
J Biol Chem. 1990;265:11083-11090.
21. Nelson MT, Standen NB, Brayden JE, Worley JF. Noradrenaline contracts arteries by activating voltage-dependent calcium channels. Nature. 1988;336:383-385.
22. Brayden JE, Quayle JM, Standen NB, Nelson MT. Role of potassium channels in the vascular response to endogenous and pharmacological vasodilators. Blood Vessels. 1991;28:147-153. [Medline] [Order article via Infotrieve]
23. Cook NS. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci. 1988;9:21-28. [Medline] [Order article via Infotrieve]
24.
Gelband CH, McCullough JR. Modulation of rabbit
aortic Ca2+ activated K+ channels by
pinacidil, cromakalim, and glibenclamide. Am J
Physiol. 1993;264:C1119-C1127.
25.
Najibi S, Cowan CL, Palacino JJ, Cohen RA.
Enhanced role of potassium channels in relaxations to
acetylcholine in hypercholesterolemic rabbit
carotid artery. Am J Physiol. 1994;266:H2061-H2067.
26.
Janigro D, West GA, Gordon EL, Winn HR.
ATP-sensitive K+ channels in rat aorta and brain microvascular
endothelial cells. Am J Physiol. 1993;265:C812-C821.
27. Luckhoff A, Busse R. Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents. Naunyn Schmiedebergs Arch Pharmacol. 1990;342:94-99. [Medline] [Order article via Infotrieve]
28. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2551.
This article has been cited by other articles:
![]() |
J. J. Andresen, F. M. Faraci, and D. D. Heistad Vasomotor responses in MnSOD-deficient mice Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1141 - H1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. S. Barreto-Filho, F. M. Consolim-Colombo, G. M. Guerra-Riccio, R. D. Santos, A. P. Chacra, H. F. Lopes, S. H. Teixeira, T. Martinez, J. E. Krieger, and E. M. Krieger Hypercholesterolemia Blunts Forearm Vasorelaxation and Enhances the Pressor Response During Acute Systemic Hypoxia Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1660 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kinoshita, Y. Kimoto, K. Nakahata, H. Iranami, M. Dojo, and Y. Hatano The Role of K+ Channels in Vasorelaxation Induced by Hypoxia and the Modulator Effects of Lidocaine in the Rat Carotid Artery Anesth. Analg., August 1, 2003; 97(2): 333 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tanaka, H. Shimokawa, H. Kamiuneten, Y. Eto, Y. Matsumoto, K. Morishige, G. Koike, M. Yoshinaga, K. Egashira, O. Tokunaga, et al. Disparity of MCP-1 mRNA and Protein Expressions Between the Carotid Artery and the Aorta in WHHL Rabbits: One Aspect Involved in the Regional Difference in Atherosclerosis Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 244 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Sobey Potassium Channel Function in Vascular Disease Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 28 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tomiyama, J. E. Brian Jr, M. M. Todd, and W. Pearce Cerebral Blood Flow During Hemodilution and Hypoxia in Rats : Role of ATP-Sensitive Potassium Channels • Editorial Comment: Role of ATP-Sensitive Potassium Channels Stroke, September 1, 1999; 30(9): 1942 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Lamping, D. W. Nuno, D. A. Chappell, and F. M. Faraci Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1023 - R1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ooboshi, K. Toyoda, F. M. Faraci, M. G. Lang, and D. D. Heistad Improvement of Relaxation in an Atherosclerotic Artery by Gene Transfer of Endothelial Nitric Oxide Synthase Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1752 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Toyoda, H. Ooboshi, Y. Chu, A. Fasbender, B. L. Davidson, M. J. Welsh, D. D. Heistad, and G. K. Steinberg Cationic Polymer and Lipids Enhance Adenovirus-Mediated Gene Transfer to Rabbit Carotid Artery • Editorial Comment Stroke, October 1, 1998; 29(10): 2181 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bonthu, D. D. Heistad, D. A. Chappell, K. G. Lamping, and F. M. Faraci Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic Mice Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2333 - 2340. [Abstract] [Full Text] |
||||
![]() |
C. Napoli, R. Paterno, F. M. Faraci, H. Taguchi, A. Postiglione, and D. D. Heistad Mildly Oxidized Low-Density Lipoprotein Impairs Responses of Carotid but Not Basilar Artery in Rabbits Stroke, November 1, 1997; 28(11): 2266 - 2272. [Abstract] [Full Text] |
||||
![]() |
K. Toyoda, K. Fujii, Y. Takata, S. Ibayashi, T. Kitazono, T. Nagao, M. Fujikawa, M. Fujishima, and F. M. Faraci Age-Related Changes in Response of Brain Stem Vessels to Opening of ATP-Sensitive Potassium Channels Stroke, January 1, 1997; 28(1): 171 - 175. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |